Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
M. Kandi, L. Hoffmann, D. Sloth Moeller, H. H. Schmidt, M. M. Knap & A. A. Khalil. (2018) Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT. Acta Oncologica 57:6, pages 813-819.
Read now
Read now
Patrik Sibolt, Wiviann Ottosson, David Sjöström, Christina Larsen & Claus F. Behrens. (2015) Adaptation requirements due to anatomical changes in free-breathing and deep-inspiration breath-hold for standard and dose-escalated radiotherapy of lung cancer patients. Acta Oncologica 54:9, pages 1453-1460.
Read now
Read now
Cai Grau, Morten Høyer, Markus Alber, Jens Overgaard, Jacob Christian Lindegaard & Ludvig Paul Muren. (2013) Biology-guided adaptive radiotherapy (BiGART) – more than a vision?. Acta Oncologica 52:7, pages 1243-1247.
Read now
Read now
Mai-Britt Bjørklund Ellegaard, Marianne Marquard Knap & Lone Hoffmann. (2013) Inter-tester reproducibility of tumour change in small cell lung cancer patients undergoing chemoradiotherapy. Acta Oncologica 52:7, pages 1520-1525.
Read now
Read now
Georg Holgersson, Even Hoye, Michael Bergqvist, Simon Ekman, Jan Nyman, Martin Helsing, Signe Friesland, Margareta Holgersson, Lars Ekberg, Thomas Blystad, Sven-Börje Ewers, Charlotte Mörth, Britta Löden, Roger Henriksson & Stefan Bergström. (2012) Swedish Lung Cancer Radiation Study Group: Predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer. Acta Oncologica 51:6, pages 759-767.
Read now
Read now
Ludvig P. Muren & Bengt Glimelius. (2011) And they lived happily ever after… The marriage of Nordic Association for Clinical Physics and Acta Oncologica. Acta Oncologica 50:6, pages 835-837.
Read now
Read now
Articles from other publishers (17)
Ali Ajdari, Zhongxing Liao, Radhe Mohan, Xiong Wei & Thomas Bortfeld. (2022) Personalized mid-course FDG-PET based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization. Physics in Medicine & Biology 67:18, pages 185015.
Crossref
Crossref
A. Harigai, A.I. Saito, T. Inoue, M. Suzuki, Y. Namba, Y. Suzuki, F. Makino, O. Nagashima, S. Sasaki & K. Sasai. (2022) The prognostic value of 18F-FDG PET/CT taken immediately after completion of radiotherapy for lung cancer treated with concurrent chemoradiotherapy: A pilot study. Cancer/Radiothérapie 26:5, pages 711-716.
Crossref
Crossref
Elizabeth E. Olanloye, Aarthi Ramlaul, Atara I. Ntekim & Segun S. Adeyemi. (2021) FDG-PET/CT and MR imaging for target volume delineation in rectal cancer radiotherapy treatment planning: a systematic review. Journal of Radiotherapy in Practice, pages 1-11.
Crossref
Crossref
H Fakir, J Chen & R K Sachs. (2018) Hypo-fractionated boost in locally advanced non-small cell lung cancer: temporal distribution of boost fractions. Physics in Medicine & Biology 63:23, pages 235018.
Crossref
Crossref
Gilles Defraene, Matthew La Fontaine, Simon van Kranen, Bart Reymen, José Belderbos, Jan-Jakob Sonke & Dirk De Ruysscher. (2018) Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume. International Journal of Radiation Oncology*Biology*Physics 102:3, pages 642-650.
Crossref
Crossref
M. Lazzeroni, J. Uhrdin, S. Carvalho, W. van Elmpt, P. Lambin, A. Dasu, P. Wersäll & I. Toma-Dasu. (2018) Evaluation of third treatment week as temporal window for assessing responsiveness on repeated FDG-PET-CT scans in Non-Small Cell Lung Cancer patients. Physica Medica 46, pages 45-51.
Crossref
Crossref
Cathy Fleming, Serena O'Keeffe, Mary Dunne, John G. Armstrong, Brendan McClean & Luis Leon Vintro. (2018) The potential for increased tumor control probability in non–small cell lung cancer with a hypofractionated integrated boost to the gross tumor volume. Medical Dosimetry 43:4, pages 352-357.
Crossref
Crossref
Francesc Casas, Sherif Abdel-Wahab, Nenad Filipovic & Branislav Jeremic. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health
260
268
.
M.L. Yap, A. Sun, J. Higgins, K. Clarke, A. Marshall, N. Becker, L.W. Le, D.C. Vines, A. Bezjak & J.-P. Bissonnette. (2016) Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer. Clinical Oncology 28:12, pages e199-e205.
Crossref
Crossref
Daniela Trani, Ala Yaromina, Ludwig Dubois, Marlies Granzier, Sarah G.J.A. Peeters, Rianne Biemans, Georgi Nalbantov, Natasja Lieuwes, Brigitte Reniers, Esther E.G.C. Troost, Frank Verhaegen & Philippe Lambin. (2015) Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake. Clinical Cancer Research 21:24, pages 5511-5518.
Crossref
Crossref
Jing Liu, Chengqiang Li, Man Hu, Jie Lu, Xiaorong Shi, Ligang Xing, Xindong Sun, Zheng Fu, Jinming Yu & Xue Meng. (2015) Exploring Spatial Overlap of High-Uptake Regions Derived From Dual Tracer Positron Emission Tomography–Computer Tomography Imaging Using 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine in Nonsmall Cell Lung Cancer Patients. Medicine 94:17, pages e678.
Crossref
Crossref
Minh Tam Truong & Nataliya Kovalchuk. (2015) Radiotherapy Planning. PET Clinics 10:2, pages 279-296.
Crossref
Crossref
Catharina M.L. Zegers, Wouter van Elmpt, Bart Reymen, Aniek J.G. Even, Esther G.C. Troost, Michel C. Öllers, Frank J.P. Hoebers, Ruud M.A. Houben, Jonas Eriksson, Albert D. Windhorst, Felix M. Mottaghy, Dirk De Ruysscher & Philippe Lambin. (2014)
In Vivo
Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging
. Clinical Cancer Research 20:24, pages 6389-6397.
Crossref
Crossref
Xiaorong Shi, Xue Meng, Xindong Sun, Ligang Xing & Jinming Yu. (2014) PET/CT imaging-guided dose painting in radiation therapy. Cancer Letters 355:2, pages 169-175.
Crossref
Crossref
M. Warren, G. Webster, D. Ryder, C. Rowbottom & C. Faivre-Finn. (2014) An Isotoxic Planning Comparison Study for Stage II–III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer?. Clinical Oncology 26:8, pages 461-467.
Crossref
Crossref
A.M. García Vicente. (2012) Recomendaciones para el uso de la PET-TC con 18F-FDG en la planificación de radioterapia. Revista Española de Medicina Nuclear e Imagen Molecular 31:6, pages 364.
Crossref
Crossref
Wouter van Elmpt, Dirk De Ruysscher, Anke van der Salm, Annemarie Lakeman, Judith van der Stoep, Daisy Emans, Eugène Damen, Michel Öllers, Jan-Jakob Sonke & José Belderbos. (2012) The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. Radiotherapy and Oncology 104:1, pages 67-71.
Crossref
Crossref